Unlock stock picks and a broker-level newsfeed that powers Wall Street.

LSE - Delayed Quote GBp

Induction Healthcare Group PLC (INHC.L)

9.50
0.00
(0.00%)
At close: 2:20:32 PM GMT+1
Loading Chart for INHC.L
  • Previous Close 9.50
  • Open 9.70
  • Bid 9.00 x --
  • Ask 10.00 x --
  • Day's Range 9.70 - 9.70
  • 52 Week Range 0.09 - 15.00
  • Volume 350,000
  • Avg. Volume 85,822
  • Market Cap (intraday) 8.916M
  • Beta (5Y Monthly) -0.53
  • PE Ratio (TTM) --
  • EPS (TTM) -0.03
  • Earnings Date Jul 2, 2025 - Jul 7, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 21.00

Induction Healthcare Group PLC provides software to healthcare professionals in the United Kingdom. The company offers Zesty, a patient engagement platform that provides smart appointment management, paperless letters, targeted questionnaires, and patient information; and Attend Anywhere for video consultations. It also offers registration, messaging, integration, and analytics and reporting platforms. Induction Healthcare Group PLC was incorporated in 2019 and is based in London, the United Kingdom.

www.inductionhealthcare.com

74

Full Time Employees

March 31

Fiscal Year Ends

Recent News: INHC.L

View More

Performance Overview: INHC.L

Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

INHC.L
5.56%
FTSE 100 (^FTSE)
5.19%

1-Year Return

INHC.L
24.00%
FTSE 100 (^FTSE)
4.67%

3-Year Return

INHC.L
83.19%
FTSE 100 (^FTSE)
16.37%

5-Year Return

INHC.L
90.36%
FTSE 100 (^FTSE)
46.87%

Compare To: INHC.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INHC.L

View More

Valuation Measures

As of 5/5/2025
  • Market Cap

    8.92M

  • Enterprise Value

    5.28M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.70

  • Price/Book (mrq)

    0.49

  • Enterprise Value/Revenue

    0.41

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -30.69%

  • Return on Assets (ttm)

    -10.21%

  • Return on Equity (ttm)

    -16.91%

  • Revenue (ttm)

    12.78M

  • Net Income Avi to Common (ttm)

    -3.45M

  • Diluted EPS (ttm)

    -0.03

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.13M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    876.88k

Research Analysis: INHC.L

View More

People Also Watch